Risk factors for inadequate antimicrobial treatment in patients with bloodstream infection
Abstract number: 1733_456
Vallés J., Calbo E., Anoro E., Fontanals D., Xercavins M., Espejo E., Serrate G., Morera M., Freixas N., Font B., Bella F., Segura F., Garau X.
Objective: Analyse the risk factors for ineffective antimicrobial therapy in patients with bloodstream infections (BI).
Methods: Prospective cohort study of adults with BI at three hospitals during one year. BI was defined as nosocomial-acquired (NA), community-acquired (CA), and healthcare-associated (HA).
Results: Of 1157 BI, 581 (50.2%) were CA, 295 (25.5%) were NA, and 281 (24.3%) were HA. Patients with NA received inadequate antimicrobial therapy in 28% of episodes, compared with 8% in CA (OR: 4.27; 95% CI, 2.86.3; p < 0.001). Patients with HA received inadequate therapy in 16% of episodes compared with 8% in CA (OR: 2.07; 95% CI, 1.33.2; p = 0.001). The difference between NA and HA episodes (28% vs 16%) was also different (OR: 2.06; 95% CI, 1.33.1; p = 0.001). Mortality among patients with adequate treatment was 18% vs 34% with inadequate treatment (p < 0.001). Multivariate logistic regression using community-acquired status as reference, identified NA episodes (OR, 1.7; 95% CI, 1.12.7), and BI of unknown origin (OR, 2.3; 95% CI, 1.43.7) as independent predictors of inadequate therapy. C. albicans (OR, 13.9; 95% CI, 3.752.2), methicillin-resistant S. aureus (OR, 6.9; 95% CI, 2.419.6), P. aeruginosa (OR, 2.4; 95% CI, 1.34.3), and coagulase-negative staphylococci (OR, 1.9; 95% CI, 1.063.5) were associated with an increased likelihood of receiving inadequate therapy. Infection due to S. pneumoniae (OR, 0.14; 95% CI, 0.030.59) and E. coli (OR, 0.2; 95% CI, 0.10.3) were associated with a decreased risk of ineffective therapy.
Conclusions: Among patients treated for BI, nosocomial-acquired episodes, unknown origin of infection, and infection due to multiresistant pathogens were an independent predictor of inadequate antimicrobial therapy.
|Session name:||European Society of Clinical Microbiology and Infectious Diseases|
|Location:||ICC, Munich, Germany|
|Back to top|